5 Follicular Lymphoma Clinical Trials in Tucson, AZ (2026)

Q: How do I join a clinical trial in Tucson?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you.

Recruiting Follicular Lymphoma Studies in Tucson

NCT07805707Recruiting

A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age

This study will compare an investigational mRNA flu vaccine with a licensed flu vaccine in adults 65 years of age and older. Participants will receive one injection and will be followed during the flu...

Tucson, AZPHASE354,000 participantsGlaxoSmithKline

View Study Details

NCT07851246Recruiting

A Study to Evaluate the Immune Response and Safety of a Vaccine Against Influenza in Adults 18-64 Years of Age

This clinical trial will study an investigational seasonal influenza vaccine in adults 18 to 64 years of age. The vaccine is based on messenger ribonucleic acid, also called mRNA. The main goals of th...

Tucson, AZPHASE33,000 participantsGlaxoSmithKline

View Study Details

NCT06091254Recruiting

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma

This study is researching an experimental drug called odronextamab, referred to as study drug. The study is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin...

Tucson, AZPHASE3822 participantsRegeneron Pharmaceuticals

View Study Details

NCT06337318Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab is a monoclonal antibody. It binds to a p...

Tucson, AZPHASE3600 participantsNational Cancer Institute (NCI)

View Study Details

NCT07032662Recruiting

IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

This is a Phase 2b study to evaluate the efficacy and safety of IMVT-1402 in adults with CIDP....

Tucson, AZPHASE2162 participantsImmunovant Sciences GmbH

View Study Details

About Follicular Lymphoma Clinical Trials in Tucson

Follicular lymphoma is the second most common type of non-Hodgkin lymphoma and is typically a slow-growing (indolent) cancer. It develops from B-cells in the lymph nodes. Treatment ranges from watchful waiting to immunotherapy, chemotherapy, and targeted agents.

There are currently 5 follicular lymphoma clinical trials recruiting participants in Tucson, AZ. These studies are seeking a combined 58,584 participants. Research is being sponsored by GlaxoSmithKline, Regeneron Pharmaceuticals, National Cancer Institute (NCI) and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Follicular Lymphoma Clinical Trials in Tucson — FAQ

Are there follicular lymphoma clinical trials in Tucson?

Yes, there are 5 follicular lymphoma clinical trials currently recruiting in Tucson, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tucson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.

Are clinical trials in Tucson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.

What follicular lymphoma treatments are being tested?

The 5 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for follicular lymphoma.

Data updated October 9, 2026 from ClinicalTrials.gov